{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:27:25Z","timestamp":1761596845367},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.ijcard.2003.06.014","type":"journal-article","created":{"date-parts":[[2004,4,18]],"date-time":"2004-04-18T13:11:32Z","timestamp":1082293892000},"page":"89-95","source":"Crossref","is-referenced-by-count":7,"title":["Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients"],"prefix":"10.1016","volume":"96","author":[{"given":"Miry","family":"Blich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bella","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7178","key":"10.1016\/j.ijcard.2003.06.014_BIB1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/bmj.318.7178.238","article-title":"Fortnightly review: anticoagulation in heart disease","volume":"318","author":"Hardman","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2003.06.014_BIB2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00019501-199502000-00002","article-title":"The epidemiology of atrial fibrillation","volume":"6","author":"Domanski","year":"1995","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.ijcard.2003.06.014_BIB3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2796.1999.00461.x","article-title":"Oral anticoagulation in nonvalvular atrial fibrillation","volume":"245","author":"Koefoed","year":"1999","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcard.2003.06.014_BIB4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-116-1-1","article-title":"The stroke prevention in atrial fibrillation investigators. Predictors of thromboembolism in atrial fibrillation 1, clinical features of patient at risk","volume":"116","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2003.06.014_BIB5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","article-title":"Epidemiological assessment of chronic atrial fibrillation and risk of stroke: the Framingham study","volume":"28","author":"Wolf","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.ijcard.2003.06.014_BIB6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/bmj.312.7022.45","article-title":"Antithrombotic treatment for atrial fibrillation","volume":"312","author":"Lip","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2003.06.014_BIB7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0002-9149(98)00247-1","article-title":"Risk factor for new thromboembolic stroke in patients > or = 62 years of age with chronic atrial fibrillation","volume":"82","author":"Aronow","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2003.06.014_BIB8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0038-1657555","article-title":"Prevention of thromboembolic events in atrial fibrilllation","volume":"78","author":"Koefoed","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2003.06.014_BIB9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian atrial fibrillation study (CAFA)","volume":"18","author":"Connolly","year":"1991","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2003.06.014_BIB10","series-title":"Principles of neurology","first-page":"777","year":"1997"},{"key":"10.1016\/j.ijcard.2003.06.014_BIB11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2003.06.014_BIB12","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijcard.2003.06.014_BIB13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"The stroke prevention in atrial fibrillation investigators. The stroke prevention in atrial fibrillation study: final results","volume":"84","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2003.06.014_BIB14","first-page":"687","article-title":"Stroke prevention in atrial fibrillation investigators. Warfarin versus Aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation 2 study","volume":"343","author":"Chesebro","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2003.06.014_BIB15","first-page":"695","article-title":"The clinical quality improvement network (CQIN) investigators. Thromboembolic prophylaxis in 3575 hospitalized patient with atrial fibrillation","volume":"14","author":"Anonymous","year":"1998","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2003.06.014_BIB16","first-page":"27","article-title":"Research group for antiarrhythmic drug therapy. Survey of atrial fibrillation and thromboembolism in the elderly: a multicenter cooperative study","volume":"33","author":"Anonymous","year":"1999","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ijcard.2003.06.014_BIB17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention in nonrheumatic atrial fibrillation after transient ischemic attack or minor stroke","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2003.06.014_BIB18","first-page":"1347","article-title":"The pharmacological basis of therapeutics","author":"Hardman","year":"1996"},{"key":"10.1016\/j.ijcard.2003.06.014_BIB19","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials","volume":"154","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2003.06.014_BIB20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/0003-4819-121-1-199407010-00008","article-title":"Medical treatment for stroke prevention","volume":"121","author":"Matchar","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2003.06.014_BIB21","first-page":"253","article-title":"Textbook of Medical Physiology","author":"Gyuton","year":"1996"},{"key":"10.1016\/j.ijcard.2003.06.014_BIB22","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/euhj.1998.1453","article-title":"Importance of left atrial appendage flow, as a predictor of thromboembolic events in patients with atrial fibrillation","volume":"20","author":"Kamp","year":"1999","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2003.06.014_BIB23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.21.1.4","article-title":"Thromboembolic complications in atrial fibrillation","volume":"21","author":"Petersen","year":"1990","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2003.06.014_BIB24","doi-asserted-by":"crossref","first-page":"24C","DOI":"10.1016\/0002-9149(90)90111-D","article-title":"Thromboembolic complications of atrial fibrillation and their prevention","volume":"65","author":"Petersen","year":"1990","journal-title":"Am. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527303004790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527303004790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T06:04:52Z","timestamp":1585721092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527303004790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0167527303004790"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2003.06.014","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}